MASSDEVICE ON CALL — Masimo (NSDQ:MASI) nabbed light-emitting diode-maker Spire Semiconductor LLC for an undisclosed amount in a move aimed at cutting costs, speeding development and spurring innovation.
Spire’s advanced LED technology was spun into a wholly owned Hudson, N.H.-based subsidiary named Masimo Semiconductor, which will develop custom components for Masimo’s devices as well as for biomedical, telecommunications, consumer products and other markets, according to a press release.
"We believe that further advancements in noninvasive blood constituent monitoring technologies are unlikely using off-the-shelf optoelectronic components," Masimo CEO & board chairman Joe Kiani said in prepared remarks. "Masimo Semiconductor will make the future possible and usher in a new era of technologic advancements for Masimo and ultimately our customers and patients."
GI Dynamics touts clinical benefit in low BMI patients with Type II diabetes
GI Dynamics (ASX:GID) released interim data from a study involving patients with Type II diabetes who ranked low on the body mass index scale, finding that those implanted with the the EndoBarrier gastrointestinal liner experienced positive results effects as far as weight loss, glycemic control and other metabolic benefits, according to a press release.
Zynex nabs NeuroDyne for $420,000
Lone Tree, Colo.-based electrotherapy and stroke rehabilitation device maker Zynex Inc. (OTC:ZYXI) acquired NeuroDyne Medical Corp., a Cambridge, Mass.-based maker of devices that evaluate and treat neurological and neuromuscular disorders, for a sum total of $420,000, according to a press release.
Mobile health startups Ginger.io and Pipette merge
Cambridge, Mass.-based Ginger.io, a behavioral analytics company spun out of MIT, merged with Pipette, a San Francisco, Calif.-based mobile health startup company focused on monitoring patients and reducing complications using patient-reported outcomes, according to a press release.
Passport Health snags enterprise scheduling systems maker Stat Technologies
Franklin, Tenn.-based Passport Health Communications Inc. purchased New Jersey-based enterprise scheduling systems developer Stat Technologies for an undisclosed amount, according to a press release.
Syneron confirms TransPharma buyout rumors, but at a much different price
Aesthetics devices maker Syneron Medical (NSDQ:ELOS) signed a definitive agreement to acquire transdermal drug delivery firm TransPharma Medical for $3.6 million in cash, according to a press release. Rumors were floating around last week that Syneron would pick up TransPharma for $15 million.